Nicorette Fruitmint (Nicotine Resinate 20%)

Nicotine Resinate, the active ingredient in Nicorette Fruitmint, is a nicotine replacement therapy presented as a 20% oral formulation for oromucosal use. It helps adults who are trying to quit smoking by reducing nicotine withdrawal symptoms. GNH USA supplies Nicorette Fruitmint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine Resinate is used in nicotine replacement therapy to support smoking cessation. - Smoking cessation: reduces cravings and withdrawal symptoms in adults attempting to quit tobacco. - Tobacco dependence: assists in gradual reduction of nicotine intake for dependent smokers. - Relapse prevention: may be used to maintain abstinence after quitting.

Common Side Effects: - Mouth irritation or soreness - Throat discomfort - Nausea or upset stomach - Hiccups - Dizziness - Headache Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Irregular heartbeat - Severe mouth ulceration - Anaphylaxis

Precautions should be observed before initiating therapy. - Assess nicotine dependence: determine the level of tobacco use before selection. - Cardiovascular risk: avoid use in patients with recent myocardial infarction or unstable angina. - Hypertension: use with caution in patients with uncontrolled high blood pressure. - Concomitant nicotine products: do not combine with other nicotine replacement therapies. - Keep out of reach of children: accidental ingestion can be harmful. - Store at ambient temperature: keep in the original pack, protect from moisture.

Nicotine Resinate may interact with several drug classes. Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase nicotine effects and cardiovascular strain. - Certain antihypertensive agents: nicotine can counteract blood pressure‑lowering effects. Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): may alter nicotine metabolism. - Antidepressants such as bupropion: additive risk of seizures. - Anticoagulants: nicotine may affect platelet function and bleeding risk.